Enantiomeric drug development: issues, considerations, and regulatory requirements.
Srinivas
N R
NR
Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.
Barbhaiya
R H
RH
Midha
K K
KK
D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation / Q000331:legislation & jurisprudence* / Q000379:methods*; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence / Q000379:methods; D006801:Humans; D013237:Stereoisomerism